Yahoo Finance Today's Research Reports on Medicure, Hamilton Thorne, Resverlogix and Aphria
NEW YORK, NY / ACCESSWIRE / July 5, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://rdinvesting.com and get exclusive access to our numerous research reports and market updates.
RDI Initiates Coverage on:
Medicure Inc.
https://rdinvesting.com/news/?ticker=MPH.V
Hamilton Thorne Ltd.
https://rdinvesting.com/news/?ticker=HTL.V
Resverlogix Corp.
https://rdinvesting.com/news/?ticker=RVX.TO
Aphria Inc.
https://rdinvesting.com/news/?ticker=APH.TO
Medicure's stock moved 1.58% higher Wednesday, to close the day at $7.07. The stock recorded a trading volume of 2,948 shares, which was below its three months average volume of 17,226 shares. In the last year, Medicure's shares have traded in a range of 5.56 - 9.20. The share price has gained 27.16% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $7.01 is greater than its 200-day moving average of $7.00. Shares of Medicure are trading at a Price to Earnings ratio of 2.57. Shares of Medicure have fallen approximately 5.1 percent year-to-date.
Access RDI's Medicure Inc. Research Report at:
https://rdinvesting.com/news/?ticker=MPH.V
On Wednesday, shares of Hamilton Thorne recorded a trading volume of 173,500 shares, which was above the three months average volume of 128,931 shares. The stock ended the day flat at 0.90. The share price has gained 34.33% from its 52-week low with a 52-week trading range of 0.67 - 0.98. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $0.88 is greater than its 200-day moving average of $0.81. Shares of the company are trading at a Price to Earnings ratio of 18.37. Shares of Hamilton Thorne have gained approximately 20 percent year-to-date.
Access RDI's Hamilton Thorne Ltd. Research Report at:
https://rdinvesting.com/news/?ticker=HTL.V
Resverlogix's stock edged 0.85% lower Wednesday, to close the day at $2.34. The stock recorded a trading volume of 1,300 shares, which was below its three months average volume of 156,185 shares. In the last year, Resverlogix's shares have traded in a range of 1.11 - 2.75. The share price has gained 110.81% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $1.75 is greater than its 200-day moving average of $1.74. Shares of Resverlogix have gained approximately 14.15 percent year-to-date.
Access RDI's Resverlogix Corp. Research Report at:
https://rdinvesting.com/news/?ticker=RVX.TO
On Wednesday, shares of Aphria recorded a trading volume of 1,488,104 shares, which was below the three months average volume of 4,377,553 shares. The stock ended the day 1.56% higher at 11.75. The share price has gained 128.60% from its 52-week low with a 52-week trading range of 5.14 - 24.75. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $12.13 is below its 200-day moving average of $13.98. Shares of the company are trading at a Price to Earnings ratio of 57.04. Shares of Aphria have fallen approximately 37.17 percent year-to-date.
Access RDI's Aphria Inc. Research Report at:
https://rdinvesting.com/news/?ticker=APH.TO
Our Actionable Research on Medicure Inc. (TSX-V: MPH.V) and Hamilton Thorne Ltd. (TSX-V: HTL.V) and Resverlogix Corp. (TSX: RVX.TO) and Aphria Inc. (TSX: APH.TO) can be downloaded free of charge at Research Driven Investing.
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
Address:
Email:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: RDInvesting.com
